Dexamethasone Pill
Phase 1Small molecule
Dexamethasone Pill is one of 16 small molecule programs targeting Postmenopausal Women. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
15
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
17 competitors in Postmenopausal Women
#DrugCompanyPhaseTrials
1Afinitor
NovartisPhase 2
Depo-Testosterone
AAzurity Pharmaceuticals
Phase 2
Cortrosyn
NovartisPhase 1
Decadron
AAspen Global Incorporated
Phase 1
Cortef
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 1
Orgalutran
OOrganon and Co
Phase 1
Phytoestrogen
CCairo University
Phase 3
Factrel
FerringPhase 1
AGA2118
AAngitia Biopharmaceuticals
Phase 2
Recombinant Human Luteinizing Hormone
Merck & Co.Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Postmenopausal Women1 trial
Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women
Active, not recruiting·LLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center·Phase 1·NCT04037605·5 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Dexamethasone Pill. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details